ZYME
Undervalued by 51.7% based on the discounted cash flow analysis.
Market cap | $751.55 Million |
---|---|
Enterprise Value | $509.83 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-4.06 |
Beta | 1.14 |
Outstanding Shares | 70,568,222 |
Avg 30 Day Volume | 672,323 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.17 |
---|---|
PEG | 73.76 |
Price to Sales | - |
Price to Book Ratio | 3.43 |
Enterprise Value to Revenue | 16.12 |
Enterprise Value to EBIT | -2.12 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data